These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 430733)

  • 41. Measles immunity in children: the 1985 national immunisation survey.
    Tobias M; Scadden J; Clements J; Patel A
    N Z Med J; 1987 May; 100(824):315-7. PubMed ID: 3451090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. False positive rubeola IgM tests.
    Jenkerson SA; Beller M; Middaugh JP; Erdman DD
    N Engl J Med; 1995 Apr; 332(16):1103-4. PubMed ID: 7898542
    [No Abstract]   [Full Text] [Related]  

  • 43. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
    Harry TO; Ogunmekan DA
    Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rubella, measles and poliomyelitis: need to re-examine immunization programme in Eastern Nigeria.
    Onubogu VU
    East Afr Med J; 1981 Dec; 58(12):946-8. PubMed ID: 7344943
    [No Abstract]   [Full Text] [Related]  

  • 45. Failure of attenuated viral vaccine in prevention of atypical measles.
    Chatterji M; Mankad V
    JAMA; 1977 Dec; 238(24):2635. PubMed ID: 579203
    [No Abstract]   [Full Text] [Related]  

  • 46. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

  • 47. Fever and rash in an adult traveler: the many masquerades of measles.
    Cunha BA; Mickail N
    Travel Med Infect Dis; 2011 Sep; 9(5):255-7. PubMed ID: 21930432
    [No Abstract]   [Full Text] [Related]  

  • 48. Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.
    Kovarik J; Gaillard M; Martinez X; Bozzotti P; Lambert PH; Wild TF; Siegrist CA
    Virology; 2001 Jun; 285(1):12-20. PubMed ID: 11414801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of measles serodiagnosis during an outbreak in a vaccinated community.
    Sekla L; Stackiw W; Eibisch G; Johnson I
    Clin Invest Med; 1988 Aug; 11(4):304-9. PubMed ID: 3168353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 51. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical and serological evaluation of live measles vaccine in India.
    Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
    Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: Adult measles with a butterfly rash-like appearance.
    Tsuruta D; Kobayashi H; Kurokawa I; Ishii M; Takekawa KE
    Dermatol Online J; 2010 Mar; 16(3):16. PubMed ID: 20233573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Status of immunity after measles vaccination (author's transl)].
    La Cauza C; Galluzzi F; Salti R
    Ann Sclavo; 1980; 22(4):545-54. PubMed ID: 7018418
    [No Abstract]   [Full Text] [Related]  

  • 55. Measles imported by returning U.S. travelers aged 6-23 months, 2001-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(13):397-400. PubMed ID: 21471945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measles transmission during air travel, United States, December 1, 2008-December 31, 2011.
    Nelson K; Marienau K; Schembri C; Redd S
    Travel Med Infect Dis; 2013; 11(2):81-9. PubMed ID: 23562445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Subacute sclerosing encephalitis: serum levels of measles antibodies].
    Cendrowski W; Polna I
    Neurol Neurochir Pol; 1973; 7(1):51-4. PubMed ID: 4690704
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 59. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
    J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measles in previously vaccinated children. An epidemiological study.
    Wyll SA; Witte JJ
    JAMA; 1971 May; 216(8):1306-10. PubMed ID: 5108448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.